Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 115980 | 4.54 |
09:34 ET | 70139 | 4.505 |
09:36 ET | 18609 | 4.49 |
09:38 ET | 9958 | 4.49 |
09:39 ET | 46391 | 4.48 |
09:41 ET | 10327 | 4.505 |
09:43 ET | 7468 | 4.51 |
09:45 ET | 10059 | 4.505 |
09:48 ET | 12214 | 4.5 |
09:50 ET | 14214 | 4.5 |
09:52 ET | 43512 | 4.49 |
09:54 ET | 34887 | 4.48 |
09:56 ET | 1431 | 4.48 |
09:57 ET | 18164 | 4.48 |
09:59 ET | 26592 | 4.495 |
10:01 ET | 27274 | 4.51 |
10:03 ET | 23923 | 4.525 |
10:06 ET | 17948 | 4.505 |
10:08 ET | 19475 | 4.515 |
10:10 ET | 6969 | 4.51 |
10:12 ET | 12614 | 4.53 |
10:14 ET | 1700 | 4.53 |
10:15 ET | 8958 | 4.515 |
10:17 ET | 26112 | 4.515 |
10:19 ET | 42310 | 4.5 |
10:21 ET | 11090 | 4.505 |
10:24 ET | 5460 | 4.5 |
10:26 ET | 14695 | 4.515 |
10:28 ET | 1805 | 4.5101 |
10:30 ET | 1943 | 4.51 |
10:32 ET | 11710 | 4.515 |
10:33 ET | 32691 | 4.51 |
10:35 ET | 52367 | 4.51 |
10:37 ET | 26926 | 4.515 |
10:39 ET | 39230 | 4.52 |
10:42 ET | 19273 | 4.51 |
10:44 ET | 23972 | 4.51 |
10:46 ET | 19839 | 4.51 |
10:48 ET | 31791 | 4.515 |
10:50 ET | 50713 | 4.515 |
10:51 ET | 59907 | 4.505 |
10:53 ET | 32134 | 4.495 |
10:55 ET | 74353 | 4.505 |
10:57 ET | 61920 | 4.485 |
11:00 ET | 37681 | 4.475 |
11:02 ET | 22339 | 4.48 |
11:04 ET | 29307 | 4.475 |
11:06 ET | 56034 | 4.465 |
11:08 ET | 48640 | 4.475 |
11:09 ET | 98611 | 4.485 |
11:11 ET | 33781 | 4.485 |
11:13 ET | 44047 | 4.495 |
11:15 ET | 22100 | 4.495 |
11:18 ET | 15970 | 4.495 |
11:20 ET | 42372 | 4.495 |
11:22 ET | 23355 | 4.495 |
11:24 ET | 24899 | 4.5 |
11:26 ET | 128501 | 4.495 |
11:27 ET | 44694 | 4.49 |
11:29 ET | 41090 | 4.485 |
11:31 ET | 32908 | 4.49 |
11:33 ET | 16802 | 4.485 |
11:36 ET | 31260 | 4.485 |
11:38 ET | 44023 | 4.485 |
11:40 ET | 29360 | 4.485 |
11:42 ET | 23428 | 4.48 |
11:44 ET | 34078 | 4.485 |
11:45 ET | 16243 | 4.48 |
11:47 ET | 24346 | 4.485 |
11:49 ET | 60417 | 4.47 |
11:51 ET | 20126 | 4.47 |
11:54 ET | 73578 | 4.455 |
11:56 ET | 54111 | 4.465 |
11:58 ET | 23959 | 4.465 |
12:00 ET | 23044 | 4.465 |
12:02 ET | 42095 | 4.465 |
12:03 ET | 19001 | 4.46 |
12:05 ET | 40313 | 4.465 |
12:07 ET | 80975 | 4.49 |
12:09 ET | 99232 | 4.475 |
12:12 ET | 13766 | 4.475 |
12:14 ET | 19666 | 4.48 |
12:16 ET | 14210 | 4.47 |
12:18 ET | 39745 | 4.46 |
12:20 ET | 18870 | 4.465 |
12:21 ET | 22716 | 4.46 |
12:23 ET | 43367 | 4.455 |
12:25 ET | 52642 | 4.455 |
12:27 ET | 32749 | 4.45 |
12:30 ET | 17196 | 4.45 |
12:32 ET | 60423 | 4.445 |
12:34 ET | 21961 | 4.445 |
12:36 ET | 90123 | 4.455 |
12:38 ET | 19846 | 4.445 |
12:39 ET | 17169 | 4.445 |
12:41 ET | 32019 | 4.45 |
12:43 ET | 68240 | 4.445 |
12:45 ET | 74345 | 4.45 |
12:48 ET | 26692 | 4.445 |
12:50 ET | 20671 | 4.445 |
12:52 ET | 47275 | 4.455 |
12:54 ET | 26102 | 4.46 |
12:56 ET | 19022 | 4.455 |
12:57 ET | 49924 | 4.4408 |
12:59 ET | 18300 | 4.445 |
01:01 ET | 98408 | 4.43 |
01:03 ET | 26768 | 4.435 |
01:06 ET | 22200 | 4.435 |
01:08 ET | 25613 | 4.425 |
01:10 ET | 24512 | 4.425 |
01:12 ET | 22115 | 4.425 |
01:14 ET | 18511 | 4.425 |
01:15 ET | 55808 | 4.41 |
01:17 ET | 31666 | 4.405 |
01:19 ET | 23202 | 4.405 |
01:21 ET | 45149 | 4.39 |
01:24 ET | 21366 | 4.395 |
01:26 ET | 20365 | 4.395 |
01:28 ET | 64189 | 4.4 |
01:30 ET | 25150 | 4.395 |
01:32 ET | 16920 | 4.395 |
01:33 ET | 22828 | 4.395 |
01:35 ET | 20297 | 4.395 |
01:37 ET | 40454 | 4.395 |
01:39 ET | 20316 | 4.395 |
01:42 ET | 23611 | 4.39 |
01:44 ET | 75998 | 4.395 |
01:46 ET | 28212 | 4.395 |
01:48 ET | 67139 | 4.405 |
01:50 ET | 56816 | 4.415 |
01:51 ET | 9570 | 4.415 |
01:53 ET | 62691 | 4.415 |
01:55 ET | 40502 | 4.42 |
01:57 ET | 49479 | 4.42 |
02:00 ET | 8219 | 4.42 |
02:02 ET | 67117 | 4.425 |
02:04 ET | 60874 | 4.4194 |
02:06 ET | 13173 | 4.415 |
02:08 ET | 15542 | 4.415 |
02:09 ET | 53266 | 4.415 |
02:11 ET | 13512 | 4.415 |
02:13 ET | 22480 | 4.415 |
02:15 ET | 22661 | 4.415 |
02:18 ET | 27516 | 4.41 |
02:20 ET | 14827 | 4.41 |
02:22 ET | 23831 | 4.415 |
02:24 ET | 19746 | 4.415 |
02:26 ET | 20945 | 4.415 |
02:27 ET | 32514 | 4.415 |
02:29 ET | 31874 | 4.415 |
02:31 ET | 55883 | 4.405 |
02:33 ET | 43688 | 4.395 |
02:36 ET | 23210 | 4.395 |
02:38 ET | 24446 | 4.395 |
02:40 ET | 68519 | 4.405 |
02:42 ET | 17630 | 4.405 |
02:44 ET | 69307 | 4.415 |
02:45 ET | 8387 | 4.415 |
02:47 ET | 58852 | 4.415 |
02:49 ET | 44196 | 4.415 |
02:51 ET | 19755 | 4.42 |
02:54 ET | 47606 | 4.41 |
02:56 ET | 15770 | 4.42 |
02:58 ET | 25912 | 4.415 |
03:00 ET | 30231 | 4.415 |
03:02 ET | 24549 | 4.41 |
03:03 ET | 28652 | 4.41 |
03:05 ET | 26814 | 4.41 |
03:07 ET | 32885 | 4.415 |
03:09 ET | 104397 | 4.425 |
03:12 ET | 21205 | 4.425 |
03:14 ET | 18600 | 4.425 |
03:16 ET | 19066 | 4.425 |
03:18 ET | 28484 | 4.425 |
03:20 ET | 18625 | 4.425 |
03:21 ET | 46911 | 4.41 |
03:23 ET | 16590 | 4.41 |
03:25 ET | 127017 | 4.425 |
03:27 ET | 11295 | 4.425 |
03:30 ET | 59483 | 4.435 |
03:32 ET | 27036 | 4.435 |
03:34 ET | 31343 | 4.425 |
03:36 ET | 34207 | 4.43 |
03:38 ET | 36510 | 4.425 |
03:39 ET | 57584 | 4.44 |
03:41 ET | 18019 | 4.435 |
03:43 ET | 23960 | 4.44 |
03:45 ET | 50158 | 4.445 |
03:48 ET | 11424 | 4.445 |
03:50 ET | 13305 | 4.44 |
03:52 ET | 147737 | 4.415 |
03:54 ET | 95358 | 4.425 |
03:56 ET | 40814 | 4.425 |
03:57 ET | 41852 | 4.425 |
03:59 ET | 915378 | 4.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.7B | -12.3x | --- |
Immunitybio Inc | 2.7B | -4.2x | --- |
Iovance Biotherapeutics Inc | 2.8B | -5.5x | --- |
Vera Therapeutics Inc | 2.5B | -20.7x | --- |
CG Oncology Inc | 2.5B | -31.5x | --- |
Edgewise Therapeutics Inc | 2.4B | -17.0x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 602.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-0.36 |
Book Value | $0.46 |
P/E Ratio | -12.3x |
Price/Sales (TTM) | 1,944.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,559.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.